experimental drug studied sirtris pharmaceuticals intended smallmolecule activator sirtuin subtype compound studied animals safety efficacy humans established animal models obesity diabetes found improve insulin sensitivity lower plasma glucose levels fat muscle liver tissue increase mitochondrial metabolic mice rendered obese diabetic feeding highfat highsugar diet study performed national institute aging found feeding chow infused highest dose beginning one year age increased mean lifespan maximum lifespan compared shortlived obese diabetic mice however treated animals still lived substantially shorter lives normalweight mice fed normal chow later study increased mean lifespan obese diabetic mice similar earlier study effect maximum lifespan normalweight mice fed standard rodent diet increased mean lifespan effect maximum since discovery claim compound activator although currently undergoing clinical development related compound reached phase ii human trials metabolic drug article relating gastrointestinal system stub help wikipedia expanding